Tradestie Institutional Equity Comparison Engine

INCY vs MXCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

INCY Overall Edge

INCY Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Incyte Genomics Inc (INCY) driven by superior Valuation, Growth & Margin while MXCT counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, INCY trades at 13.3x Forward P/E with 32.2% operating margin (+14.0% YoY revenue) versus MXCT at N/M Forward P/E and -85.5% operating margin (+48.7% YoY). In options structure, INCY sits in CONSOLIDATION (37th %ile IV; Dealer Gamma Walls on Pro) against MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner INCY
INCY 13.3x vs MXCT N/M Fwd P/E
Growth & Margin Winner INCY
Op Margin 32.2% vs -85.5% ยท YoY +14.0% vs +48.7%
Momentum & Technical Winner MXCT
1Y +13.1% vs -19.4% ยท 52W Pos 58% vs 63%
Options & Structure Winner MXCT
CONSOLIDATION (37th %ile IV) vs UNCLASSIFIED (N/A IV)
INCY NASDAQ
Incyte Genomics Inc
Services-Commercial Physical & Biological Research
$114.62
-1.07% 1D
Market Cap $23.6B
1M Return -1.97%
1Y Return +13.13%
Forward P/E 13.3x
Unified AI Score
54.6 / 100 HOLD
Tech 43.0 Fund 50.0 Flow 59.0 Mom 50.0
MXCT NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap $132.2M
1M Return -4.2%
1Y Return -19.41%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 46.0 Fund 52.0 Flow 62.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: INCY +13.13% MXCT -19.41% Spread: +32.54 pp (INCY Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period INCY Revenue MXCT Revenue INCY Op. Margin MXCT Op. Margin Margin Edge
FY2018 $1.88B N/A 6.9% N/A INCY
FY2019 $2.16B $10M 18.6% -93.7% INCY
FY2020 $2.67B $20M -9.9% -71.6% INCY
FY2021 $2.99B $20M 19.6% -84.3% INCY
FY2022 $3.39B $30M 17.1% -95.2% INCY
FY2023 $3.70B $20M 16.8% -247.7% INCY
FY2024 $4.24B $20M 1.4% -230.5% INCY
FY2025 $5.14B $20M 29.5% -247.6% INCY

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: INCY (8) vs MXCT (2)
Institutional Metric INCY MXCT Criterion Row Winner
Market Capitalization Scale $23.6B $132.2M Larger Scale INCY
Trailing P/E Ratio Valuation 59.1x N/M Lower Multiple INCY
Forward P/E Ratio Valuation 13.3x N/M Lower Multiple INCY
Revenue Growth (YoY) Growth +14.0% +48.7% Higher Growth MXCT
Operating Margin (TTM) Profitability 32.2% -85.5% Higher Margin INCY
Net Profit Margin Profitability 6.7% -81.4% Higher Margin INCY
Return on Equity (ROE) Capital Efficiency 7.8% -16.9% Higher ROE INCY
52-Week Range Position Momentum 58% ($89โ€“$133) 63% ($1โ€“$2) Stronger Trend MXCT
Beta / 30D Volatility Risk Regime 0.30ฮฒ ยท 31% Vol 1.19ฮฒ ยท 96% Vol Lower Realized Risk INCY
Unified Institutional Score Composite Signal 54.6 / 100 (HOLD) 41.7 / 100 (SELL) Higher Composite INCY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full INCY vs MXCT Buy Guide
INCY CONSOLIDATION
82d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live INCY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MXCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MXCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither INCY nor MXCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.